DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Paridaens R, Biganzoli L, Bruning P. et al.
Paclitaxel vs doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: A European Organization for Research and Treatment of Cancer randomized study with cross over.
J Clin Oncol 2000; 18: 724-733
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.